Despite the contention that drug companies make about the safety of their products, most drugs, including powerful antibiotics like Levaquin contain dangers for patients undergoing treatment. According to Public Citizen, a non-profit consumer advocacy group, Levaquin is responsible for causing a large number of ruptured tendons in people undergoing Levaquin treatment.
Recently, the FDA approved of “black-box” labeling for Levaquin, indicating the risks of possible tendon rupture. Physicians and patients should be aware of the signs and symptoms of tendon problems:
- Tendon pain
The FDA’s adverse events database shows the following statistics between November 1997 and December 2005:
- 262 tendon ruptures
- 258 cases of tendonitis
- 274 other tendon problems
Those numbers are for all fluoroquinolone type antibiotics, with a full 61% associated with Levaquin specifically. Drug companies are driven by profits and frequently let people suffer while they make money. Instead of minimizing the risks of potentially dangerous drugs, they invest in marketing their products to an ever-wider consumer base.
Pharmaceutical litigators, like Schlichter, Bogard & Denton are here to protect the general public from out of control drug companies. If you or a loved one has suffered any adverse effects related to a Levaquin course of treatment, you may be eligible to seek compensation for those injuries.
Please contact the knowledgeable dangerous drug attorneys at Schlichter, Bogard & Denton to schedule a confidential, no-cost consultation.